202 related articles for article (PubMed ID: 26526157)
21. Prognostic role of survivin in renal cell carcinoma: A system review and meta-analysis.
Xiong C; Liu H; Chen Z; Yu Y; Liang C
Eur J Intern Med; 2016 Sep; 33():102-7. PubMed ID: 27350406
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: a systematic review and meta-analysis.
Zhang L; Zha Z; Qu W; Zhao H; Yuan J; Feng Y; Wu B
BMC Cancer; 2018 Sep; 18(1):870. PubMed ID: 30176824
[TBL] [Abstract][Full Text] [Related]
23. The prognostic value of vascular endothelial growth factor in patients with renal cell carcinoma: a systematic review of the literature and meta-analysis.
Shen H; Liu Q; Li M; Yang P
Clin Invest Med; 2017 Apr; 40(2):E40-E48. PubMed ID: 28447576
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature.
Zhao Z; Liao G; Li Y; Zhou S; Zou H; Fernando S
PLoS One; 2014; 9(11):e114096. PubMed ID: 25426861
[TBL] [Abstract][Full Text] [Related]
25. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis.
Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R
Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942
[TBL] [Abstract][Full Text] [Related]
26. Prognostic and Clinicopathological Significance of Survivin Expression in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Xie Y; Ma X; Gu L; Li H; Chen L; Li X; Gao Y; Fan Y; Zhang Y; Yao Y; Zhang X
Sci Rep; 2016 Jul; 6():29794. PubMed ID: 27411378
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Significance of Cyclin D1 Expression in Renal Cell Carcinoma: a Systematic Review and Meta-analysis.
Li Z; Liu J; Zhang X; Fang L; Zhang C; Zhang Z; Yan L; Tang Y; Fan Y
Pathol Oncol Res; 2020 Jul; 26(3):1401-1409. PubMed ID: 31748879
[TBL] [Abstract][Full Text] [Related]
28. Silencing of CXCR4 by RNA interference inhibits cell growth and metastasis in human renal cancer cells.
Wang L; Huang T; Chen W; Gao X; Zhou T; Wu Z; Sun Y
Oncol Rep; 2012 Dec; 28(6):2043-8. PubMed ID: 22972438
[TBL] [Abstract][Full Text] [Related]
29. High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinoma.
An H; Xu L; Zhu Y; Lv T; Liu W; Liu Y; Liu H; Chen L; Xu J; Lin Z
Br J Cancer; 2014 Apr; 110(9):2261-8. PubMed ID: 24714746
[TBL] [Abstract][Full Text] [Related]
30. MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.
Gu L; Li H; Chen L; Ma X; Gao Y; Li X; Zhang Y; Fan Y; Zhang X
Oncotarget; 2015 Oct; 6(32):32545-60. PubMed ID: 26416448
[TBL] [Abstract][Full Text] [Related]
31. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.
Hu Q; Gou Y; Sun C; Ding W; Xu K; Gu B; Xia G; Ding Q
Urol Oncol; 2014 Jan; 32(1):50.e1-8. PubMed ID: 24239465
[TBL] [Abstract][Full Text] [Related]
32. The impact of chemokine receptor CXCR4 on breast cancer prognosis: a meta-analysis.
Xu TP; Shen H; Liu LX; Shu YQ
Cancer Epidemiol; 2013 Oct; 37(5):725-31. PubMed ID: 23763828
[TBL] [Abstract][Full Text] [Related]
33. The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis.
Qiu L; Xu Y; Xu H; Yu B
BMC Cancer; 2022 Jun; 22(1):681. PubMed ID: 35729596
[TBL] [Abstract][Full Text] [Related]
34. Differential role of CD133 and CXCR4 in renal cell carcinoma.
D'Alterio C; Cindolo L; Portella L; Polimeno M; Consales C; Riccio A; Cioffi M; Franco R; Chiodini P; Cartenì G; Mirone V; Longo N; Marra L; Perdonà S; Claudio L; Mascolo M; Staibano S; Falsaperla M; Puglisi M; Martignoni G; Ficarra V; Castello G; Scala S
Cell Cycle; 2010 Nov; 9(22):4492-4500. PubMed ID: 21127401
[TBL] [Abstract][Full Text] [Related]
35. MiRNA-1246 suppresses the proliferation and migration of renal cell carcinoma through targeting CXCR4.
Liu HT; Fan WX
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):5979-5987. PubMed ID: 32572911
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of CXCR4 in ovarian cancer: a meta-analysis.
Liu CF; Liu SY; Min XY; Ji YY; Wang N; Liu D; Ma N; Li ZF; Li K
PLoS One; 2014; 9(3):e92629. PubMed ID: 24658065
[TBL] [Abstract][Full Text] [Related]
37. Phosphatase and tensin homolog (PTEN) expression on oncologic outcome in renal cell carcinoma: A systematic review and meta-analysis.
Tang L; Li X; Gao Y; Chen L; Gu L; Chen J; Lyu X; Zhang Y; Zhang X
PLoS One; 2017; 12(7):e0179437. PubMed ID: 28672019
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis.
Li X; Ma X; Chen L; Gu L; Zhang Y; Zhang F; Ouyang Y; Gao Y; Huang Q; Zhang X
Sci Rep; 2015 Aug; 5():13157. PubMed ID: 26287771
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylated 4EBP1 is associated with tumor progression and poor prognosis in Xp11.2 translocation renal cell carcinoma.
Qu Y; Zhao R; Wang H; Chang K; Yang X; Zhou X; Dai B; Zhu Y; Shi G; Zhang H; Ye D
Sci Rep; 2016 Mar; 6():23594. PubMed ID: 27026382
[TBL] [Abstract][Full Text] [Related]
40. HDAC6 serves as a biomarker for the prognosis of patients with renal cell carcinoma.
Zhang Z; Cao Y; Zhao W; Guo L; Liu W
Cancer Biomark; 2017; 19(2):169-175. PubMed ID: 28128740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]